Home
About
Overview
Sharing Data
ORCID
Help
History (11)
Receptor, Melanocortin, Type 1
Tuberculosis, Urogenital
Psychrobacter
Inflammation Mediators
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
See All 11 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst. 1997 Nov 19; 89(22):1673-82.
View in:
PubMed
subject areas
Antimetabolites, Antineoplastic
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms
Chemotherapy, Adjuvant
Cyclophosphamide
Disease-Free Survival
Estrogen Antagonists
Female
Fluorouracil
Humans
Lymphatic Metastasis
Methotrexate
Middle Aged
Neoplasm Recurrence, Local
Receptors, Estrogen
Risk
Survival Analysis
Tamoxifen
Treatment Failure
Treatment Outcome
authors with profiles
James Dignam